Abstract
Outstanding work on the cellular and molecular aspects of radioresistance has been published in the past 10 years [1,2]. The work presented herein does not attempt to be comprehensive but is a review of the work of our laboratory as it pertains to aspects of radioresistance with potential applicability to chemotherapy/cytokine radiotherapy interactions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Peters LJ, Brock WA, Johnson T, Meyn RE, Tofilon PJ, Milas L. Potential methods for predicting tumor radiocurability. Int J Radiat Oncol Biol Phys 12:459–467, 1986.
Brock WA, Baker FL, Wike JL, Sivon SL, Peters LJ. Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys 18:1283–1286, 1990.
Weichselbaum RR, Dahlberg W, Beckett MA, Karrison T, Miller D, Clark J, Ervin TJ. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head and neck cancer patients. Proc Natl Acad Sci USA 83:2684–2688, 1986.
Weichselbaum RR, Beckett MA, Vijayakumar S, Simon MA, Awan AA, Nachman J, Panje WR, Goldman ME, Tybor AG, Moran WJ, Vokes EE, Ahmed-Swan S, Farhangi, E. Radiobiological characterization of head and neck sarcoma cells derived from patients prior to radiotherapy. Int J Radiat Oncol Biol Phys 19:313–319, 1990.
Weichselbaum RR, Beckett MA, Schwartz JL, Dritschilo A. Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int J Radiat Oncol Biol Phys 15:575–579, 1988.
Weichselbaum RR, Nove J, Little JB. Radiation response of human tumor cells in vitro. In: RH Withers, R Meyn, eds. Radiation Biology and Cancer Research. New York: Raven Press, 1980, pp 345–351.
Elkind MM, Sutton H. X-ray damage and recovery in mammalian cells in culture. Nature 184:1293–1295, 1969.
Elkind MM. Fractionated dose radiotherapy and its relationship to survival curve shapes. Cancer Treat Rev 3:2–15, 1976.
Nilsson S, Carlsson J, Larsson B. Survival of irradiated glia and glioma cells studied with a new cloning technique. Int J Radiat Biol 37:267–279, 1980.
Weichselbaum RR, Dahlberg W, Little JB. Inherently radioresistant cells exist in some human tumors. Proc Natl Acad Sci USA 87:4732–4735, 1985.
Weichselbaum RR, Nove J, Little JB. X-ray sensitivity of 53 human diploid fibroblast cell strains from patients with characterized genetic disorders. Cancer Res 40:920–925, 1980.
Withers HR. Biological basis of radiation therapy. In: CA Peres, LW Brady, eds. Principles and Practice of Radiation Oncology. Philadelphia: JB Lippincott, 1987, pp 67–98.
Phillips RA, Tolmach LJ. Repair of potentially lethal damage in x-irradiated HeLa cells. Radiat Res 29:413–432, 1966.
Weichselbaum RR, Nove J, Little JB. Deficient recovery from potentially lethal radiation damage in ataxia telangiectasia and xeroderma pigmentosum. Nature 27:261–262, 1978.
Weichselbaum RR, Schmit A, Little JB. Cellular repair factors influencing radiocurability of human malignant tumors. Br J Cancer 45:10–16, 1982.
Weichselbaum RR, Little JB. The differential response of human tumors to fractionated radiation may be due to a post-irradiation repair process. Br J Cancer 46:532–537, 1982.
Weichselbaum RR, Beckett MA. The maximum recovery potential of human tumor cells may predict clinical outcome in radiotherapy. Int J Radiat Oncol Biol Phys 13:709–713, 1987.
Fu KK, Phillips TL. Biologic rationale of combined radiotherapy and chemotherapy. Hemotol/Oncol Clin North Am 5:737–751, 1991.
Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 8:911–934, 1990.
Quiet C, Weichselbaum RR, Gradina D. Variation in radiation sensitivity during the cell cycle to two human squamous cell carcinomas. Int J Radiat Oncol Biol Phys 20:733–738, 1991.
Vokes EE, Panje WR, Schilsky RL, Mick R, Awan AM, Moran WJ, Goldman MD, Tybor AG, Weichselbaum RR. Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: A phase I-II study. J Clin Oncol 7:761–768, 1989.
Haraf DJ, Vokes EE, Panje WR, Weichselbaum RR. Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer. Am J Clin Oncol 14:419–426, 1991.
Weppelmann B, Wheeler RA, Peters GE, Kim RY, Spencer SA, Meredith RF, Salter MM. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea and reirradiation. Int J Radiat Oncol Biol Phys 22:1051–1056, 1992.
Guillot T, Wibault P, Cvitkovit E, Luboinski E, Tellez B, Eschwege F, Schwaab G, Armand JP. Treatment of ‘favorable’ recurrent (REC) head and neck squamous cell cancer (H+NSCC) with 5 days on/9 days simultaneous chemoradiotherapy (CH/RT) Vokes-Weichselbaum (VW) protocol (abstract #684). Proc Am Soc Clin Oncol 9:177, 1990.
Vokes EE, Beckett M, Karrison T, Weichselbaum RR. The interaction of 5-fluorouracil, hydroxyurea and radiation in two human head and neck cancer cell lines. Oncology 49:454–460, 1992.
Bohr VA, Evans MK, Fornace AJ. DNA repair and its pathogenetic implications. Lab Invest 61:143–161, 1989.
Thompson LH, Brookman KW, Jones NJ, Allen SA, Carrano AV. Molecular cloning of the human XRCC-1 gene, which corrects defective DNA strand break repair and sister chromatid exchange. Mol Cell Biol 10:6160–6171, 1990.
Dunphy EJ, Beckett MA, Thompson LH, Weichselbaum RR. Expression of the polymorphic human DNA repair gene XRCC-1 does not correlate with radiosensitivity in human head and neck tumor cell lines. Radiat Res 130:166–170, 1992.
Weinert TA, Hartwell LH. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241:317–322, 1988.
Mitchell JB, Cook JA, DeGraff W, Glatstein E, Russo A. Glutathione modulation in cancer treatment: Will it work? Int J Radiat Oncol Biol Phys 16:1289–1295, 1989.
Fitzgerald TJ, Daugherty C, Kase K, Rothstein LA, McKenna M, Greenberger JS. Activated human n-ras oncogene enhances x-irradiation repair of mammalian cells in vitro less efficiently at low dose rates. Am J Clin Oncol 8:517–522, 1985.
Sklar MD. The ras-oncogenes increase the intrinsic resistance of NIH/3T3 cells to ionizing radiation. Science 239:645–657, 1989.
Kasid U, Pfeifer A, Weichselbaum RR, Dritschilo A, Mark GE. The raf-oncogene is associated with the radiation-resistant human laryngeal cancer. Science 237:1039–1041, 1987.
Kasid U, Pfeifer A, Brennan T, Beckett MA, Weichselbaum RR, Dritschilo A, Mark GE. Effect of anti-sense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous cell carcinoma. Science 243:1354–1356, 1989.
Pirollo KF, Garner R, Yuan SY, Li L, Blather WA, Chang EH. Raf involvement in the simultaneous genetic transfer of the radioresistant and transforming phenotypes. Int J Radiat Biol 55:783–796, 1989.
Horiguchi J, Spriggs D, Imamura K, Stone R, Leubbers R, Kufe D. Role of arachidonic acid metabolism in transcriptional induction of tumor necrosis factor gene expression by phorbol ester. Mol Cell Biol 9:252–258, 1989.
Rozengurt E, Rodriguez-Pena A, Coombs M, Sinnett-Smith J. Diacylglycerol stimulates DNA synthesis and cell division in mouse 3T3 cells: Role of Ca+ 2-sensitive phospholipid-dependent protein kinase. Proc Natl Acad Sci USA 81:5748–5752, 1984.
Hallahan D, Virudachalam S, Sherman ML, Huberman E, Kufe DW, Weichselbaum RR. Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation. Cancer Res 51:4565–4569, 1991.
Hallahan DE, Sukhatme VP, Sherman ML, Virudachalam S, Kufe D, Weichselbaum RR. Protein kinase C mediates x-ray inducibility of nuclear signal transducers, egr-1 and c-jun. Proc Natl Acad Sci USA 88:2152–2160, 1991.
Hallahan DE, Virudachalam S, Schwartz JL, Panje N, Mustafi R, Weichselbaum RR. Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation. Radiat Res 129:345–350, 1992.
Witte L, Fuks Z, Haimovitz-Friedman A, Vlodavsky I, Goodman DS, Eldor A. Effects of radiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. Cancer Res 49:5066–5072, 1989.
Haimovitz-Friedman A, Vlodavsky I, Chaudhuri A, Witte L, Fuks Z. Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res 51:2552–2558, 1991.
Hallahan DE, Spriggs DR, Beckett MA, Kufe DW, Weichselbaum RR. Increased tumor necrosis factor-alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci USA 86:10104–10107, 1989.
Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, Kufe DW. Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. J Clin Invest 87:1794–1797, 1991.
Hallahan DE, Beckett MA, Kufe D, Weichselbaum RR. Interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines. Int J Radiat Oncol Biol Phys 19:69–74, 1990.
Neta R, Oppenheim JJ, Schreiber RD, Chizzonite R, Ledney GD, Mac Vittie T. Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance. J Exp Med 173:1177–1182, 1991.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Weichselbaum, R.R. et al. (1995). Cellular and molecular mechanisms of radioresistance. In: Hong, W.K., Weber, R.S. (eds) Head and Neck Cancer. Cancer Treatment and Research, vol 74. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2023-8_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2023-8_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5837-4
Online ISBN: 978-1-4615-2023-8
eBook Packages: Springer Book Archive